Clade C gp140

glycoprotein 140 · Janssen Vaccines & Prevention B.V.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Clade C gp140, covering 2025-02-03 to 2025-02-03. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Tolerability and Immunogenicity Study of Different Vaccine Schedules With Ad26.Mos.HIV and Clade C Glycoprotein (gp)140 in Healthy Human Immunodeficiency Virus (HIV)-Uninfected Adults [Phase 1]

See pricing